• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重温滴答理论:C3 是一种接触激活蛋白吗?

The tick-over theory revisited: is C3 a contact-activated protein?

机构信息

Department of Immunology, Genetics and Pathology, Rudbeck Laboratory C5:3, Uppsala University, Sweden.

出版信息

Immunobiology. 2012 Nov;217(11):1106-10. doi: 10.1016/j.imbio.2012.07.008.

DOI:10.1016/j.imbio.2012.07.008
PMID:22964236
Abstract

The tick-over theory was first introduced in the 1970s to explain the presence of the initial C3b molecules, which are able to trigger complement activation by the alternative pathway in human plasma under physiological conditions. After the identification of the thioester, the predominant hypothesis has been that this bond is hydrolyzed at a slow but constant rate by nucleophilic attack by H(2)O, leading to the generation of C3(H(2)O). Here we put forward the hypothesis that the rate of hydrolysis of C3 to C3(H(2)O) may be greatly accelerated by the interaction between C3 and a number of biological and artificial interfaces, including gas bubbles, biomaterial surfaces and different lipid surfaces and complexes. We therefore propose that C3 should preferentially be regarded as a contact activated protein rather than a target for passive, random hydrolysis in the fluid phase.

摘要

迟滞理论最初于 20 世纪 70 年代被引入,用以解释初始 C3b 分子的存在。在生理条件下,初始 C3b 分子能够通过人血浆中的替代途径触发补体激活。硫酯确定后,主要假说认为,该键通过 H(2)O 的亲核攻击以缓慢但恒定的速率水解,导致 C3(H(2)O)的生成。在这里,我们提出假设,C3 与许多生物和人工界面(包括气泡、生物材料表面和不同的脂质表面和复合物)之间的相互作用可能大大加速 C3 水解为 C3(H(2)O)的速率。因此,我们提出 C3 应该优先被视为接触激活蛋白,而不是在液相中被动、随机水解的靶标。

相似文献

1
The tick-over theory revisited: is C3 a contact-activated protein?重温滴答理论:C3 是一种接触激活蛋白吗?
Immunobiology. 2012 Nov;217(11):1106-10. doi: 10.1016/j.imbio.2012.07.008.
2
Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.由活化的人血小板释放的酪蛋白激酶磷酸化所引起的C3激活和结合的改变。
J Immunol. 1999 Jun 15;162(12):7426-33.
3
Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.替代补体途径初始C3转化酶的形成。通过天然C3中假定硫酯的自发水解获得C3b样活性。
J Exp Med. 1981 Sep 1;154(3):856-67. doi: 10.1084/jem.154.3.856.
4
Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3.由于C3硫酯的自发水解而启动替代补体途径。
Ann N Y Acad Sci. 1983;421:291-8. doi: 10.1111/j.1749-6632.1983.tb18116.x.
5
Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.抗体可恢复经链霉蛋白酶预处理而功能缺陷的小鼠红细胞对人替代补体途径的激活作用。
J Immunol. 1982 Mar;128(3):1302-6.
6
Kallikrein Cleaves C3 and Activates Complement.激肽释放酶裂解 C3 并激活补体。
J Innate Immun. 2018;10(2):94-105. doi: 10.1159/000484257. Epub 2017 Dec 14.
7
Assessment of the Role of C3(HO) in the Alternative Pathway.评估 C3(HO) 在替代途径中的作用。
Front Immunol. 2020 Mar 31;11:530. doi: 10.3389/fimmu.2020.00530. eCollection 2020.
8
Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.活化的人血小板释放的酪蛋白激酶使C3磷酸化,这增加了免疫复合物的调理作用以及与1型补体受体的结合。
Eur J Immunol. 2001 Apr;31(4):1047-54. doi: 10.1002/1521-4141(200104)31:4<1047::aid-immu1047>3.0.co;2-y.
9
Generation of multiple fluid-phase C3b:plasma protein complexes during complement activation: possible implications in C3 glomerulopathies.在补体激活过程中生成多种液相 C3b:血浆蛋白复合物:可能对 C3 肾小球疾病有影响。
J Immunol. 2014 Feb 1;192(3):1220-30. doi: 10.4049/jimmunol.1302288. Epub 2013 Dec 23.
10
Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.补体成分C2,可抑制补体激活经典途径中的一种潜在丝氨酸蛋白酶。
Biochemistry. 2009 Sep 8;48(35):8466-72. doi: 10.1021/bi900679r.

引用本文的文献

1
Chronic kidney disease enhances alternative pathway activity: a new paradigm.慢性肾脏病增强替代途径活性:一种新范式。
J Clin Invest. 2025 May 1;135(9). doi: 10.1172/JCI188353.
2
Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration.苔藓衍生的人补体因子H调节视网膜免疫反应并减轻视网膜变性。
J Neuroinflammation. 2025 Apr 11;22(1):104. doi: 10.1186/s12974-025-03418-2.
3
Cryo-EM analysis of complement C3 reveals a reversible major opening of the macroglobulin ring.补体C3的冷冻电镜分析揭示了巨球蛋白环的一个可逆性主要开口。
Nat Struct Mol Biol. 2025 May;32(5):884-895. doi: 10.1038/s41594-024-01467-4. Epub 2025 Jan 23.
4
Complement biosensors identify a classical pathway stimulus in complement-mediated thrombotic microangiopathy.补体生物传感器可识别补体介导的血栓性微血管病中的经典途径刺激物。
Blood. 2024 Dec 12;144(24):2528-2545. doi: 10.1182/blood.2024025850.
5
Pre-Clinical Studies of a Novel Bispecific Fusion Protein Targeting C3b and VEGF in Neovascular and Nonexudative AMD Models.新型双特异性融合蛋白靶向新生血管性和非渗出性年龄相关性黄斑变性模型中C3b和VEGF的临床前研究
Ophthalmol Ther. 2024 Aug;13(8):2227-2242. doi: 10.1007/s40123-024-00982-3. Epub 2024 Jun 21.
6
Comprehensive functional characterization of complement factor I rare variant genotypes identified in the SCOPE geographic atrophy cohort.全面功能表征在 SCOPE 地图萎缩队列中鉴定的补体因子 I 罕见变异基因型。
J Biol Chem. 2024 Jul;300(7):107452. doi: 10.1016/j.jbc.2024.107452. Epub 2024 Jun 7.
7
Molecular mechanism of complement inhibition by the trypanosome receptor ISG65.锥虫受体ISG65抑制补体的分子机制
Elife. 2024 Apr 24;12:RP88960. doi: 10.7554/eLife.88960.
8
Sex- and species-associated differences in complement-mediated immunity in humans and rhesus macaques.人类和恒河猴补体介导免疫中的性别和物种相关差异。
mBio. 2024 Mar 13;15(3):e0028224. doi: 10.1128/mbio.00282-24. Epub 2024 Feb 22.
9
Microbial evasion of the complement system: a continuous and evolving story.微生物逃避补体系统:一个持续不断的演变故事。
Front Immunol. 2024 Jan 4;14:1281096. doi: 10.3389/fimmu.2023.1281096. eCollection 2023.
10
Sex and species associated differences in Complement-mediated immunity in Humans and Rhesus macaques.人类和恒河猴中补体介导免疫的性别及物种相关差异
bioRxiv. 2023 Oct 25:2023.10.23.563614. doi: 10.1101/2023.10.23.563614.